Resveratrol potential fires interest in longevity drugs

Interest in longevity drugs continues to grow as new research points to the tonic effects of resveratrol. The New York Times notes that some scientists have become so enamored by the potential of the ingredient they have begun to take it in pill form. And the implications could be huge for any developer like Sirtris.

"The upside is so huge that if we are right, the company that dominates the sirtuin space could dominate the pharmaceutical industry and change medicine," said Dr. David Sinclair of the Harvard Medical School, a co-founder of the company.

- read the article in The New York Times

Suggested Articles

Vital strategies for steriles development to ensure more flexibility within drug development.

After Mallinckrodt's terlipressin beat placebo at reversing kidney failure, an FDA panel will discuss the phase 3 trial's surrogate endpoint.

Operation Warp Speed is living up to its name as AstraZeneca is teaming up with IQVIA to boost its R&D for its pandemic shot.